BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2179793)

  • 1. Pharmacokinetics of estrogen.
    Stumpf PG
    Obstet Gynecol; 1990 Apr; 75(4 Suppl):9S-14S; discussion 15S-17S. PubMed ID: 2179793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
    Baker VL
    Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and pharmacology of estrogens in pre- and postmenopausal women.
    Anderson F
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():55-64. PubMed ID: 8499960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17 beta-estradiol for postmenopausal estrogen replacement therapy.
    Nichols KC; Schenkel L; Benson H
    Obstet Gynecol Surv; 1984 Apr; 39(4):230-45. PubMed ID: 6717863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
    Balfour JA; Heel RC
    Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement.
    Powers MS; Schenkel L; Darley PE; Good WR; Balestra JC; Place VA
    Am J Obstet Gynecol; 1985 Aug; 152(8):1099-106. PubMed ID: 2992279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics and efficacy of different estrogens are not equivalent.
    Ansbacher R
    Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of estrogen and progesterone in chronic kidney disease.
    Anderson GD; Odegard PS
    Adv Chronic Kidney Dis; 2004 Oct; 11(4):357-60. PubMed ID: 15492972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, multiple-dose parallel study to compare the pharmacokinetic parameters of synthetic conjugated estrogens, A, administered as oral tablet or vaginal cream.
    Bhamra RK; Margolis MB; Liu JH; Hendy CH; Jenkins RG; DiLiberti CE
    Menopause; 2011 Apr; 18(4):393-9. PubMed ID: 21107298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
    L'Hermite M
    Climacteric; 2017 Aug; 20(4):331-338. PubMed ID: 28301216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms.
    Carroll N
    J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparative study for the clinical evaluation of hormone replacement by transdermal and oral routes.
    Polvani F; Zichella L; Bocci A; Bottiglioni F; Cagnazzo G; Campagnoli C; Carenza L; Cianci S; Danesino V; De Cecco L
    Clin Exp Obstet Gynecol; 1991; 18(4):207-13. PubMed ID: 1790601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal hormone therapy for urogenital and menopausal symptoms.
    Ballagh SA
    Semin Reprod Med; 2005 May; 23(2):126-40. PubMed ID: 15852198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogens--pharmacokinetics and pharmacodynamics with special reference to vaginal administration and the new estradiol formulation--Estring.
    Johnston A
    Acta Obstet Gynecol Scand Suppl; 1996; 163():16-25. PubMed ID: 8916471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transdermal and oral hormone substitution with estrogens: a comparison].
    Schindler AE
    Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and pharmacokinetics of estrogens.
    Lievertz RW
    Am J Obstet Gynecol; 1987 May; 156(5):1289-93. PubMed ID: 3578450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacologic variation between different estrogen products.
    O'Connell MB
    J Clin Pharmacol; 1995 Sep; 35(9S):18S-24S. PubMed ID: 8530713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.